Gilead Sciences, Inc. (GILD) P/E Ratio History
Historical price-to-earnings valuation from 2001 to 2025
Loading P/E history...
GILD Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Gilead Sciences, Inc. (GILD) trades at a price-to-earnings ratio of 358.7x, with a stock price of $136.30 and trailing twelve-month earnings per share of $6.79.
The current P/E is 254% above its 5-year average of 101.3x. Over the past five years, GILD's P/E has ranged from a low of 11.9x to a high of 931.6x, placing the current valuation at the 95th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, GILD trades at a 1519% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, GILD commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GILD DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GILD P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $363B | 86.5 | - | -1% | |
| $115B | 16.4 | - | +178% | |
| $179B | 23.3 | 7.91 | +88% | |
| $28B | 21.6 | - | -21% | |
| $75B | 17.4 | 2.75 | +8% | |
| $109B | 27.9 | 3.37 | +837% | |
| $280B | 15.6 | 0.73Best | +8% | |
| $151B | 19.5 | - | -4% | |
| $541B | 38.8 | - | -58% | |
| $20B | 15.6Lowest | - | +4173%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
GILD Historical P/E Data (2001–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $122.74 | $6.77 | 18.1x | -65% |
| FY2025 Q3 | $111.00 | $6.45 | 17.2x | -67% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $110.87 | $5.02 | 22.1x | -58% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $112.05 | $4.75 | 23.6x | -55% |
| FY2024 Q4 | $92.37 | $0.37 | 249.6x | +377% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $83.84 | $0.09 | 931.6x | +1681% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $68.61 | $0.82 | 83.7x | +60% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $73.25 | $0.36 | 203.5x | +289% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $81.01 | $4.50 | 18.0x | -66% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $74.94 | $4.66 | 16.1x | -69% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $77.07 | $4.35 | 17.7x | -66% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $82.97 | $4.43 | 18.7x | -64% |
Average P/E for displayed period: 52.3x
Full GILD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy GILD Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See GILD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GILD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GILD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGILD — Frequently Asked Questions
Quick answers to the most common questions about buying GILD stock.
Is GILD stock overvalued or undervalued?
GILD trades at 358.7x P/E, above its 5-year average of 101.3x. The 95th percentile ranking indicates a premium to historical valuation.
How does GILD's valuation compare to peers?
Gilead Sciences, Inc. P/E of 358.7x compares to sector median of 22.2x. The premium reflects expected growth above peers.
What is GILD's PEG ratio?
GILD PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2001-2025.